The influence of cytokines on the complex pathology of ulcerative colitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The influence of cytokines on the complex pathology of ulcerative colitis
Authors
Keywords
Ulcerative colitis, Complex pathology, Cytokine
Journal
AUTOIMMUNITY REVIEWS
Volume 21, Issue 3, Pages 103017
Publisher
Elsevier BV
Online
2021-12-11
DOI
10.1016/j.autrev.2021.103017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future
- (2021) Geert R D'Haens et al. GUT
- Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
- (2021) Takeshi Kuwada et al. GASTROENTEROLOGY
- Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases
- (2021) Anja Schulz-Kuhnt et al. Frontiers in Medicine
- Soluble ligands as drug targets for treatment of inflammatory bowel disease
- (2021) Xuhui Tong et al. PHARMACOLOGY & THERAPEUTICS
- Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients
- (2020) Lorenzo Bertani et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block
- (2020) Gionata Fiorino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cytokines in inflammatory bowel diseases – Update 2020
- (2020) M. Leppkes et al. PHARMACOLOGICAL RESEARCH
- Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment
- (2020) Loris Riccardo Lopetuso et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Role of the IL-23-T-bet/GATA3 Axis for the Pathogenesis of Ulcerative Colitis
- (2020) Haruei Ogino et al. INFLAMMATION
- Ulcerative colitis
- (2020) Taku Kobayashi et al. Nature Reviews Disease Primers
- Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
- (2019) Tomas Castro-Dopico et al. IMMUNITY
- Mucosal and Systemic Immune Profiles Differ During Early and Late Phases of the Disease in Patients With Active Ulcerative Colitis
- (2019) Georgios Mavroudis et al. Journal of Crohns & Colitis
- I_MDS: an inflammatory bowel disease molecular activity score to classify patients with differing disease-driving pathways and therapeutic response to anti-TNF treatment
- (2019) Stelios Pavlidis et al. PLoS Computational Biology
- IL-12 and Mucosal CD14+ Monocyte-Like Cells Induce IL-8 in Colonic Memory CD4+ T Cells of Patients With Ulcerative Colitis but not Crohn’s Disease
- (2019) Laurence Chapuy et al. Journal of Crohns & Colitis
- Targeting immune cell circuits and trafficking in inflammatory bowel disease
- (2019) Markus F. Neurath NATURE IMMUNOLOGY
- Expression Levels of 4 Genes in Colon Tissue Might be Used to Predict Which Patients Will Enter Endoscopic Remission After Vedolizumab Therapy for Inflammatory Bowel Diseases
- (2019) Bram Verstockt et al. Clinical Gastroenterology and Hepatology
- IL-13 mRNA tissue content identifies two subsets of adult ulcerative colitis patients with different clinical and mucosa-associated microbiota profiles
- (2019) Alessia Butera et al. Journal of Crohns & Colitis
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis
- (2019) Nobuyuki Kakiuchi et al. NATURE
- Somatic inflammatory gene mutations in human ulcerative colitis epithelium
- (2019) Kosaku Nanki et al. NATURE
- Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype
- (2018) James D. Lord et al. CLINICAL IMMUNOLOGY
- Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-label Trial of Patients With Ulcerative Colitis
- (2018) Shannon E. Telesco et al. GASTROENTEROLOGY
- Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients
- (2018) Igor Vladimirovich Obraztsov et al. INFLAMMATORY BOWEL DISEASES
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
- (2017) Nathaniel R West et al. NATURE MEDICINE
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study
- (2016) Tasuku Suzuki et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis
- (2016) Yoichiro Iboshi et al. JOURNAL OF GASTROENTEROLOGY
- Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications
- (2016) Daniel Muthas et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy
- (2016) Angela C Baird et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Genetic characteristics of inflammatory bowel disease in a Japanese population
- (2015) Yuta Fuyuno et al. JOURNAL OF GASTROENTEROLOGY
- First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis—results from a multicenter prospective randomized controlled trial and its post hoc analysis
- (2015) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy
- (2015) Rahil Dahlén et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Targeting Leukocyte Trafficking for the Treatment of Inflammatory Bowel Disease
- (2015) KO Arseneau et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- IBD Candidate Genes and Intestinal Barrier Regulation
- (2014) Declan F. McCole INFLAMMATORY BOWEL DISEASES
- Innate and adaptive immunity in inflammatory bowel disease
- (2013) Alessandra Geremia et al. AUTOIMMUNITY REVIEWS
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
- (2013) Yasuo Suzuki et al. JOURNAL OF GASTROENTEROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation
- (2012) Franziska Boehm et al. BMC GASTROENTEROLOGY
- Healing of intestinal inflammation by IL-22
- (2012) Atsushi Mizoguchi INFLAMMATORY BOWEL DISEASES
- Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity
- (2012) Daniel S. Pearl et al. Journal of Crohns & Colitis
- Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis
- (2012) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Gene Expression Profiling and Response Signatures Associated With Differential Responses to Infliximab Treatment in Ulcerative Colitis
- (2011) Gary Toedter et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- New IBD genetics: common pathways with other diseases
- (2011) C. W. Lees et al. GUT
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
- (2011) Saskia Thomas et al. INFLAMMOPHARMACOLOGY
- Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
- (2010) Mingli Xu et al. Clinical & Developmental Immunology
- IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation
- (2009) Juan Peng et al. CELL RESEARCH
- TNF-alpha gene expression in colorectal mucosa as a predictor of remission after induction therapy with infliximab in ulcerative colitis
- (2009) Trine Olsen et al. CYTOKINE
- Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
- (2009) I. Arijs et al. GUT
- A protective function for interleukin 17A in T cell–mediated intestinal inflammation
- (2009) William O'Connor Jr et al. NATURE IMMUNOLOGY
- Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
- (2009) Erik-Oliver Glocker et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-23 and Th17 Cells Enhance Th2-Cell–mediated Eosinophilic Airway Inflammation in Mice
- (2008) Hidefumi Wakashin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(−/−) mice
- (2008) Andrew Collett et al. INFLAMMATORY BOWEL DISEASES
- Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis
- (2008) Philip Alex et al. INFLAMMATORY BOWEL DISEASES
- Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis
- (2008) S Fichtner-Feigl et al. Mucosal Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now